InnoPharmax Inc. (4172.TWO)

TWD 16.45

(4.44%)

Operating Expenses Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual operating expenses in 2023 was 82.29 Million TWD , down -11.94% from previous year.
  • InnoPharmax Inc.'s latest quarterly operating expenses in 2024 Q2 was 26.72 Million TWD , down -4.51% from previous quarter.
  • InnoPharmax Inc. reported a annual operating expenses of 93.45 Million TWD in annual operating expenses 2022, up 13.11% from previous year.
  • InnoPharmax Inc. reported a annual operating expenses of 82.62 Million TWD in annual operating expenses 2021, down -4.57% from previous year.
  • InnoPharmax Inc. reported a quarterly operating expenses of 26.72 Million TWD for 2024 Q2, down -4.51% from previous quarter.
  • InnoPharmax Inc. reported a quarterly operating expenses of 20.52 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Operating Expenses of InnoPharmax Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 82.29 Million TWD -11.94%
2022 93.45 Million TWD 13.11%
2021 82.62 Million TWD -4.57%
2020 86.57 Million TWD -29.07%
2019 122.05 Million TWD 0.0%

Peer Operating Expenses Comparison of InnoPharmax Inc.

Name Operating Expenses Operating Expenses Difference
Allied Biotech Corporation 157.72 Million TWD 47.823%
GeneFerm Biotechnology Co., Ltd. 132.78 Million TWD 38.024%
Easywell Biomedicals, Inc. 333.45 Million TWD 75.32%
TTY Biopharm Company Limited 1.91 Billion TWD 95.695%
Synmosa Biopharma Corporation 1.49 Billion TWD 94.512%
Orient EuroPharma Co., Ltd. 2.14 Billion TWD 96.167%
Center Laboratories, Inc. 697.35 Million TWD 88.199%
Tien Liang BioTech Co., Ltd. 267.27 Million TWD 69.209%
Orient Pharma Co., Ltd. 468.66 Million TWD 82.44%
Johnson Chemical Pharmaceutical Works Co., Ltd. 244.63 Million TWD 66.359%
Excelsior Biopharma Inc. 388.05 Million TWD 78.793%
DV Biomed Co., Ltd. 575.24 Million TWD 85.694%
Foresee Pharmaceuticals Co., Ltd. 1.12 Billion TWD 92.663%
Handa Pharmaceuticals, Inc. 399.14 Million TWD 79.382%
UniPharma Co., Ltd. 78.32 Million TWD -5.075%
Anxo Pharmaceutical Co., Ltd. 396.93 Million TWD 79.267%
Alar Pharmaceuticals Inc. 83.74 Million TWD 1.73%
Winston Medical Supply Co., Ltd. 151.49 Million TWD 45.678%
Mercury Biopharmaceutical Corporation 592 Thousand TWD -13801.351%
Bioray Biotech Co., Ltd 96.98 Million TWD 15.143%
TSH Biopharm Corporation Limited 336.26 Million TWD 75.527%